Yup really
Effective August 23, 2020 the issuer’s subsidiary, SomaCeuticals, Inc. entered into an exclusive global license agreement with 7 to Stand, Inc. for the rights to U.S. patent 10,610,592 issued to Fabrizio de Silvestri, Terni, Italy, as inventor, April 7, 2020 for treatment of Multiple Sclerosis(MS). On August 12, 2020 James C. Katzaroff was elected President of the subsidiary and authorized to clear the patented pharmaceutical with FDA and oversee international marketing.